Evidence map›Paper›PMID 14630947›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2003

Fragile site orthologs FHIT/FRA3B and Fhit/Fra14A2: evolutionarily conserved but highly recombinogenic.

Ayumi Matsuyama, Takeshi Shiraishi, Francesco Trapasso, Tamotsu Kuroki, Hansjuerg Alder, Masaki Mori, Kay Huebner, Carlo M Croce

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Nit1 and Fhit tumor suppressor activities are additive.Journal of cellular biochemistry · 2009
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Ayumi MatsuyamaKimmel Cancer Center, Thomas Jefferson University, 233 South 10th Street, Philadelphia, PA 19107, USA.
Takeshi Shiraishi
Francesco Trapasso
Tamotsu Kuroki
Hansjuerg Alder
Masaki Mori
Kay Huebner
Carlo M Croce
Kyushu University · JPSidney Kimmel Cancer Center · USThomas Jefferson University · US

Funding

X-Ray Crystallography and Macromolecular CharacterizationP30CA056036 · NCI · THOMAS JEFFERSON UNIVERSITY · PI DANIEL P SILVER · 1995 to 2026
$94.8M
ROLE OF THE FHIT LOCUS IN ENVIRONMENTAL CARCINOGENESISP01CA077738 · NCI · THOMAS JEFFERSON UNIVERSITY · PI HUEBNER, KAY · 2000 to 2004
$5.6M
NCI NIH HHS P01 CA077738NCI NIH HHS P01 CA77738NCI NIH HHS P30 CA056036NCI NIH HHS P30 CA56036
6 · The paper itself

Abstract

Common fragile sites are regions that show elevated susceptibility to DNA damage, leading to alterations that can contribute to cancer development. FRA3B, located at chromosome region 3p14.2, is the most frequently expressed human common fragile site, and allelic losses at FRA3B have been observed in many types of cancer. The FHIT gene, encompassing the FRA3B region, is a tumor-suppressor gene. To identify the features of FHIT/FRA3B that might contribute to fragility, sequences of the human FHIT and the flanking PTPRG gene were compared with those of murine Fhit and Ptprg. Human and mouse orthologous genes, FHIT and Fhit, are more highly conserved through evolution than PTPRG/Ptprg and yet contain more sequence elements that are exquisitely sensitive to genomic rearrangements, such as high-flexibility regions and long interspersed nuclear element 1s, suggesting that common fragile sites serve a function. The conserved AT-rich high-flexibility regions are the most characteristic of common fragile sites.

Indexed as

Acid Anhydride HydrolasesChromosome Fragile SitesEvolution, MolecularGenes, Tumor SuppressorRecombination, GeneticAnimalsBis(5'-adenosyl)triphosphataseConserved SequenceDatabases, GeneticDNADNA DamageExonsHumansMiceMolecular Sequence DataNeoplasm ProteinsAcid Anhydride HydrolasesBis(5'-adenosyl)triphosphataseDNANeoplasm Proteins

Identifiers

PMID14630947
PMCPMC299872
OpenAlexW2155180441

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.